SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-024708
Filing Date
2022-10-25
Accepted
2022-10-25 16:52:00
Documents
15
Period of Report
2022-10-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20221025_8k.htm   iXBRL 8-K 31451
2 EXHIBIT 3.1 ex_436724.htm EX-3.1 11106
3 EXHIBIT 3.2 ex_436733.htm EX-3.2 12003
  Complete submission text file 0001437749-22-024708.txt   199942

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acrx-20221025.xsd EX-101.SCH 3602
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20221025_def.xml EX-101.DEF 12304
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20221025_lab.xml EX-101.LAB 16509
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20221025_pre.xml EX-101.PRE 12570
9 EXTRACTED XBRL INSTANCE DOCUMENT acrx20221025_8k_htm.xml XML 2751
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 221330027
SIC: 2834 Pharmaceutical Preparations